Purine metabolism in normal and HIV-1 infected lymphocytes. Purine nucleotide content. 1992

R Pagani, and A Tabucchi, and F Carlucci, and M C Re, and M Rubino, and F Ciccomascolo, and E Marinello, and A Siccardi
Ist. Biochimica e Enzimologia, Università di Siena.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D011685 Purine Nucleotides Purines attached to a RIBOSE and a phosphate that can polymerize to form DNA and RNA. Nucleotides, Purine
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D002461 Cell Line, Transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Transformed Cell Line,Cell Lines, Transformed,Transformed Cell Lines
D002472 Cell Transformation, Viral An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus. Transformation, Viral Cell,Viral Cell Transformation,Cell Transformations, Viral,Transformations, Viral Cell,Viral Cell Transformations
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

R Pagani, and A Tabucchi, and F Carlucci, and M C Re, and M Rubino, and F Ciccomascolo, and E Marinello, and A Siccardi
May 1996, Biochemical Society transactions,
R Pagani, and A Tabucchi, and F Carlucci, and M C Re, and M Rubino, and F Ciccomascolo, and E Marinello, and A Siccardi
January 2000, Advances in experimental medicine and biology,
R Pagani, and A Tabucchi, and F Carlucci, and M C Re, and M Rubino, and F Ciccomascolo, and E Marinello, and A Siccardi
January 1980, Journal of immunological methods,
R Pagani, and A Tabucchi, and F Carlucci, and M C Re, and M Rubino, and F Ciccomascolo, and E Marinello, and A Siccardi
October 1987, Archives of biochemistry and biophysics,
R Pagani, and A Tabucchi, and F Carlucci, and M C Re, and M Rubino, and F Ciccomascolo, and E Marinello, and A Siccardi
May 1997, Biochimica et biophysica acta,
R Pagani, and A Tabucchi, and F Carlucci, and M C Re, and M Rubino, and F Ciccomascolo, and E Marinello, and A Siccardi
January 1989, Advances in experimental medicine and biology,
R Pagani, and A Tabucchi, and F Carlucci, and M C Re, and M Rubino, and F Ciccomascolo, and E Marinello, and A Siccardi
January 1927, The Biochemical journal,
R Pagani, and A Tabucchi, and F Carlucci, and M C Re, and M Rubino, and F Ciccomascolo, and E Marinello, and A Siccardi
January 1978, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
R Pagani, and A Tabucchi, and F Carlucci, and M C Re, and M Rubino, and F Ciccomascolo, and E Marinello, and A Siccardi
June 1979, Blut,
R Pagani, and A Tabucchi, and F Carlucci, and M C Re, and M Rubino, and F Ciccomascolo, and E Marinello, and A Siccardi
January 1999, Nature medicine,
Copied contents to your clipboard!